GO
Loading...

GlaxoSmithKline PLC

More

  • Shares of Array BioPharma soared Friday after the drug developer said it will buy worldwide rights to a potential cancer treatment in late-stage clinical testing from Swiss pharmaceutical giant Novartis. The Boulder, Colorado, company said the deal is conditional on Novartis closing some acquisitions with British drugmaker GlaxoSmithKline PLC that it...

  • LONDON, Jan 23- The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said. The World Health Organization said on Thursday the Ebola outbreak in West Africa, the worst in history, appears to be waning but cautioned against complacency.

  • *Disease outbreaks high on Davos agenda after Ebola. DAVOS, Switzerland, Jan 23- The worst-ever Ebola epidemic is waning, but after ravaging three West African nations and spreading fear from Dallas to Madrid, it has hammered home the message that the world needs a better detective system for emerging diseases. Risks posed by pandemic threats such as deadly...

  • LONDON, Jan 23- The first batch of GlaxoSmithKline's experimental Ebola vaccine has been shipped to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said. The vaccine, co-developed by the National Institutes of Health in the United States and Okairos, a biotechnology firm acquired by GSK in 2013, is currently being tested...

  • DAVOS, Switzerland, Jan 22- The GAVI global vaccines alliance is seeking to raise $7.5 billion at a funding conference in Berlin next week, as its battle to prevent infectious diseases in millions of children reaches an expected peak. The economic benefits of that will be some $80 billion and $100 billion, underscoring the cost-effectiveness of vaccines as a...

  • INSIGHT-The smoke around e-cig science Thursday, 22 Jan 2015 | 6:00 AM ET

    *Wide variety of e-cigs a problem for researchers. *Tobacco firms join e-cig companies in sponsoring research. LONDON, Jan 22- From Apple Pie to Bubbly Bubble Gum, Irish Car Bomb or Martian bar- from Mars!

  • DAVOS, Switzerland, Jan 21- Takeda Pharmaceutical, Japan's largest drugmaker, is ready to look at doing deals now that it has refocused operations, its incoming chief executive said on Wednesday. "We don't want to be passive and we don't want to watch the train passing," he told Reuters on the fringes of the World Economic Forum in Davos. As COO, Weber has overseen a...

  • LONDON, Jan 20- the international charity Medecins Sans Frontieres urged drugmakers GlaxoSmithKline and Pfizer on Tuesday to slash the price of their pneumococcal vaccines to $5 per child in poor countries. Pfizer also said its pneumococcal shot, Prevenar 13, was highly complex. It said GSK and Pfizer had together reported more than $19 billion in global...

  • LONDON, Jan 16- Johnson& Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros from Europe's Innovative Medicines Initiative to speed development. The new initiative will see J&J join with institutions including the London School of Hygiene& Tropical Medicine, the University of...

  • LONDON, Jan 16- GlaxoSmithKline is feeling the heat from the rapid growth in electronic cigarettes, with enthusiasm for the nicotine delivery devices dampening sales of the British drugmaker's patches and gum, its chief executive said. In an interview with Reuters, Andrew Witty also said he and his team had spent "a few days" exploring whether the drugmaker...

  • *Consumer more tenable as standalone business after Novartis deal. Chief Executive Andrew Witty told Reuters the group's large consumer health business would be more viable as a standalone operation following the conclusion of a $20 billion asset swap with Novartis, especially if it bought additional assets. "Post- Novartis, particularly if we did more...

  • Jan 15- Researchers believe they have discovered a mechanism by which tumors eventually evade effective combination treatments for melanoma, providing clues that could lead to longer-lasting therapies for the deadliest of skin cancers. Roger Lo of the UCLA Jonsson Comprehensive Cancer Center, looked at tumor samples from 15 melanoma patients prior to...

  • SHANGHAI, Jan 9- China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc.. The policy would help reform a fragmented and opaque market controlled by state-run distributors and hospitals, brought into...

  • *Initial Phase I clinical study starts in Britain. *First tests in Britain, more planned in U.S. and Africa. LONDON, Jan 6- Johnson& Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

  • LONDON, Jan 6- Vectura Group, a respiratory drugs specialist, will work with Janssen Biotech to develop treatments for asthma and lung disease COPD, it said on Tuesday. Janssen, a unit of Johnson& Johnson, will then use Vectura's dry powder inhaler technologies in the development of inhaled therapeutics for airways-related diseases such as asthma, a market worth...

  • *Initial Phase I clinical study starts at Oxford University. *Further tests planned for United States and Africa. LONDON, Jan 6- Johnson& Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

  • Early movers: DTV, WMT, UPS, GSK, SNE & more Wednesday, 24 Dec 2014 | 7:46 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Dec 23- The U.S. Department of Health and Human Services awarded contracts worth a total of about $43 million to NewLink Genetics Corp and GlaxoSmithKline Plc for faster development of two Ebola vaccines. Under a $30 million contract, NewLink's unit BioProtection Systems Corp will conduct clinical trials to determine the lowest dose at which its vaccine...

  • Dec 22- The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's intravenous flu drug, sending the company's shares up nearly 10 percent in premarket trading. The single-dose drug is for adults who have acute uncomplicated influenza and may be unable to swallow pills, such as Gilead Sciences Inc's Tamiflu, or inhale GlaxoSmithKline...

  • GENEVA, Dec 19- Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information. Countries where the trials are planned-- Cameroon, Ghana, Mali, Nigeria and Senegal-- should receive and review the additional...